A better understanding of phosphorylation sites may lead to new approaches for sensitizing cancer cells to HSP90 inhibitors and overcoming resistance (Mollapour et al., 2010; Iwai et al., 2012; Lokeshwar, 2012). The gene discussed is HSP90AA1; the disease is cancer.